Loading
Everything OnCo dates to 1964: 15 entries, 7 landmarks, 4 technologies, 2 approvals and 1 law or regulation. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
15 dated entries in OnCo fall in 1964: 7 landmarks, 4 technologies, 2 approvals, 1 law or regulation and 1 paper.
Of those, 15 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Wilms tumour, rhabdomyosarcoma, Ewing sarcoma, gestational trophoblastic neoplasia, metastatic testicular cancer, regional perfusion for sarcoma
Multiple myeloma; non-resectable epithelial ovarian carcinoma
The statutes, regulations, guidance and court rulings in the law index, dated to the year the instrument was made.
International, declaration.
The publication year on key paper records.
LAIRD AK. British Journal of Cancer.
The history entries editors wrote on cancer records: the dated turning points of each disease.
Low-risk gestational trophoblastic neoplasia (FIGO score 0 to 6)
Burkitt lymphoma. Epstein, Achong and Barr identify the first human tumour virus.
Hepatocellular carcinoma. Nobel Prize 1976; leads to the vaccine.
Advanced-stage classical Hodgkin lymphoma (stage III to IV)
Hodgkin lymphoma
Hodgkin lymphoma
Undifferentiated pleomorphic sarcoma (UPS)
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.